ISAL 2023 | How COVID-19 has impacted patients with hematological malignancies
Livio Pagano, MD, Catholic University of Sacred Heart, Rome, Italy, shares some insights into how the COVID-19 pandemic impacted patients with hematological malignancies, and further comments on the important role that vaccines have played in reducing risk of mortality. This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Board member of Gilead Science, MSD, Pfizer, Stemline, Basilea, Janssen-Cilab, Novartis, Jazz Pharmaceutical, Cidara and has been speaker for Gilead Sciences, Kiowa Kirin, MSD, Pfizer Pharmaceuticals, Astellas Pharma, Novartis, Jazz Pharmaceutical. Consultant for Menarini
